We found 15 matching results
Digital health experts and fund managers are working to support the growth and development of a number of promising early stage digital health businesses that have shown potential in addressing identified health and care needs within the NHS.
Looking to grow your digital health business? DH.L is providing screening and evaluation of promising early stage digital health businesses to address health and care needs across the NHS.
Thank you to all of you that registered and came to this months’ 5x5x5 event which was themed: ARTIFICIAL INTELLIGENCE. The event was an absolute success with our biggest turnout to date, which is a great end to the year. We’re also happy to announce the winner of the 5x5x5 event this month: Congrats, Peter Klesken […]
We are delighted to have been commissioned by RYSE Asset Management LLP to provide screening and evaluation of promising early stage digital health businesses. Using our extensive networks and market knowledge of the health and care sector, we will assess the feasibility of, and the clinical needs met by companies, with a view to introducing a small number of them to the firm.
Lyfebulb and Novo Nordisk are partnering to host the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award. They are looking for international Patient Entrepreneurs who are developing innovative ideas and concepts using consumer, medical devices, and healthcare IT aimed at positively empowering and impacting the lives of people living with type 1 or type 2 diabetes.
Interested in applying for the next SBRI Healthcare competition? The next funding round focuses on finding innovative solutions with the ability to transform screening, accelerated diagnosis and management of cancer.
The London Co-Investment Fund is founded and managed by Funding London and Capital Enterprise. It has raised £25m from the Mayor of London’s Growing Places Fund to co-invest in seed rounds between £250,000- £1,000,000, led by our selected co-investment partners. The London Co-investment Fund is looking to invest in high growth tech, science and digital startups […]
GLP) is an investment programme, designed to prepare startups for their next round of funding; we act as an intermediary between startups and the venture capital community.
UK businesses can apply for a share of £8.5 million to fund feasibility studies in infrastructure systems or health and life sciences.
The International Call for Ideas (5rd of April- 16th of July 2017) targets early stage projects in drug delivery, diagnostics (medical devices), digital health, wearables and big data areas. The acceleration program provides training, mentoring and advisory by international experts, and the access to the international investors. Best startups can receive up to €100 000 seed investment per project.